Moreover, we found that the levels of EZH2 and CD82 were 4-fold and 6-fold higher, respectively, in CD34+/CD38− AML cells compared with CD34+/CD38+ cells (n = 10; Fig 1C). The gene discussed is CD34; the disease is acute myeloid leukemia.